EUVIMEDEUVIMED entdecken
Crossref

Characterization of Viscum album L. Effect on Immune Escape Proteins PD-L1, PD-L2, and MHC-I in the Prostate, Colon, Lung, and Breast Cancer Cells

Seema Devi, Carsten Gründemann, Roman Huber, Stefanie Kowarschik

Complementary Medicine Research · 2023 · 30 (5) · 386-392

DOI: 10.1159/000530184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Complementary Medicine Research, online erschienen am 16.03.2023. Verfasst von Seema Devi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Complementary Medicine, Department of Internal Medicine II, Faculty of Medicine, University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Viscum album, Breast Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Viscum album L. (VA) preparations possess immunomodulatory properties and are used in complementary medicine to support cancer therapy. It is unclear if there is an impact of VA on the expression of immune checkpoint proteins on the surface of cancer cells. This study was designed to investigate the role of commercially available VA preparations on checkpoint programmed death ligand 1, 2 (PD-L1, PD-L2) and on major histocompatibility complex class I (MHC-I).

Methods

Four human cancer cell lines (prostate, colon, lung, and breast) were assayed for their PD-L1, PD-L2, and MHC-I level after stimulation with interferon-gamma (IFN-γ). The toxicity of mistletoe preparations for the cells was analysed. Afterwards, the effect of mistletoe preparations on the PD ligands and MHC-I was investigated.

Results

Surface protein analysis demonstrated that all tested tumour cell lines increased the PD-L1, PD-L2, and MHC-I-expression, but to different extents, after IFN-γ stimulation. Treatment with VA extracts did not influence the viability of the cells. The expression of PD ligands and MHC-I was not affected by incubation with the VA preparations.

Conclusion

Our investigation concludes that VA treatment does not interfere with the expression of PD ligands or MHC-I among selected cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Viscum albumBreast NeoplasmsMaleHumansB7-H1 AntigenInterferon-gammaProstateLungColon

Stichwörter der Autor:innen

CancerInteractionMHC-IPD ligandsViscum album

Substanzen

CD274 protein, humanB7-H1 AntigenInterferon-gamma

Autor:innen und Institutionen

  • Centre for Complementary Medicine, Department of Internal Medicine II, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Translational Complementary Medicine, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.

Zitieren

APA

Devi, S., Gründemann, C., Huber, R., & Kowarschik, S. (2023). Characterization of Viscum album L. Effect on Immune Escape Proteins PD-L1, PD-L2, and MHC-I in the Prostate, Colon, Lung, and Breast Cancer Cells. Complementary Medicine Research, 30(5), 386-392. https://doi.org/10.1159/000530184

Vancouver

Devi S, Gründemann C, Huber R, Kowarschik S. Characterization of Viscum album L. Effect on Immune Escape Proteins PD-L1, PD-L2, and MHC-I in the Prostate, Colon, Lung, and Breast Cancer Cells. Complementary Medicine Research. 2023;30(5):386-392. doi:10.1159/000530184

BibTeX
@article{Devi2023,
  author = {Devi, Seema and Gründemann, Carsten and Huber, Roman and Kowarschik, Stefanie},
  title = {Characterization of Viscum album L. Effect on Immune Escape Proteins PD-L1, PD-L2, and MHC-I in the Prostate, Colon, Lung, and Breast Cancer Cells},
  journal = {Complementary Medicine Research},
  year = {2023},
  volume = {30},
  number = {5},
  pages = {386--392},
  doi = {10.1159/000530184}
}
Kostenlos starten →